All you need to know about the symptoms of Omicron
Omicron Symptoms: How Does the New COVID-19 Variant Differ from Previous Variants?
South African data shows that people infected with the Omicron variant may develop a scratchy or sore throat, nasal congestion, a dry cough and muscle pain, particularly in the lower back. Unlike earlier COVID-19 variants, Omicron appears to produce symptoms that are much more similar to those of a common cold. According to a UK study, an Omicron-positive individual may initially experience a sore throat, runny nose and headache, making the infection difficult to distinguish from an ordinary respiratory illness.
As India's Omicron case count reached 415 on December 25, medical specialists were working to better understand the symptoms of this rapidly transmissible variant and determine how they differ from those associated with earlier variants, particularly Delta. Preliminary observations from South Africa indicated that sore throat, nasal congestion, dry cough and muscle pain were frequently reported. Meanwhile, data collected through the Zoe C-19 study app, a non-profit initiative supporting COVID-19 research in collaboration with King's College London, revealed that some of the most common symptoms among confirmed Omicron cases included a runny nose, headaches, fatigue, sore throat and sneezing. These findings suggested a noticeable shift in the clinical presentation of the infection, with symptoms increasingly resembling those of a seasonal cold.
Clearly, an Omicron-positive individual may feel much more like someone experiencing a common cold, with symptoms often starting with a sore throat, runny nose and headache, according to the Zoe C-19 study and several news reports. However, these cold-like symptoms are not included in the original list established by the UK government, which identifies a high temperature, a new continuous cough and a loss or change in the sense of smell or taste as the main symptoms of COVID-19. Nevertheless, the Zoe app's analysis and observations from the Scientific Advisory Group for Emergencies (SAGE) suggested that early evidence pointed towards a lower frequency of smell and taste loss among Omicron patients.
How Does Omicron's Symptoms Vary from Other Variants?
One of the most noticeable differences between Omicron and previous COVID-19 variants is the reduced frequency of smell and taste loss. While these symptoms were widely associated with earlier infections, Omicron appears to be more frequently characterized by upper respiratory manifestations such as a runny nose, sneezing and sore throat. Despite these differences, infection specialists believe that there is still considerable overlap between Omicron and previous variants because they are essentially causing the same underlying viral infection. However, scientists have identified another important distinction: Omicron seems to have a shorter incubation period. Following exposure, some individuals may develop symptoms, become contagious and test positive in as little as three days. This is considerably shorter than the four-to-six-day period generally observed with Delta and the original coronavirus strain. Researchers suggested that mutations in Omicron may help the virus attach to and enter human cells, potentially influencing how quickly the infection develops.
Is Omicron Milder Than Other COVID-19 Variants?
The severity of Omicron infections has become a major concern for researchers and public health authorities. Preliminary data released by South Africa showed that adults diagnosed with Omicron had a 29 per cent lower risk of hospitalization compared with individuals diagnosed during the first wave of the pandemic. Hospitalized South African COVID-19 patients were also less likely to require admission to intensive care units. Meanwhile, Britain's public health agency released preliminary findings suggesting that people infected with Omicron were between 50 and 70 per cent less likely to require hospitalization than those infected with Delta. However, the agency warned that the analysis was preliminary and highly uncertain because the number of Omicron patients admitted to hospitals remained relatively small and many infected individuals belonged to younger age groups. Therefore, although these initial findings suggested that Omicron might cause less severe disease in certain populations, they did not mean that the variant was harmless or incapable of causing serious complications.
Omicron Symptoms and Vaccination Status: What Is the Difference?
Vaccination status may also influence the symptoms experienced by individuals infected with different COVID-19 variants. Observations suggested that vaccinated people infected with Delta or the original coronavirus strain commonly experienced headaches, nasal congestion, sinus pressure and sinus pain, whereas unvaccinated patients were more likely to report shortness of breath and coughing accompanied by flu-like symptoms. Among vaccinated Omicron patients, headaches, body aches and fever were frequently reported, with some describing the infection as being similar to a particularly bad cold.
Omicron Symptoms and Vaccination Status: What Is the Difference
According to recent ZOE data based on a London study, the five most frequently reported Delta symptoms among individuals who had received two vaccine doses were headache, runny nose, sneezing, sore throat and loss of smell. In comparison, the five most common Omicron symptoms were runny nose, headache, fatigue (mild or severe), sneezing and sore throat. Loss of appetite and brain fog were also identified as common symptoms. This comparison highlights how the clinical presentation of COVID-19 can evolve between variants, with Omicron appearing to produce symptoms that more closely resemble those of an ordinary respiratory infection.
Bottom Line: Can Omicron Still Cause Severe Illness?
Although preliminary findings suggested that Omicron might be associated with a lower risk of hospitalization than previous variants, scientists have emphasized that it can still cause severe illness. Mild symptoms during the early stages of infection do not necessarily mean that the disease will remain mild, as some patients may develop more serious symptoms later. This is why individuals experiencing cold or flu-like symptoms should not automatically assume that they have an ordinary cold. Testing, staying at home when experiencing symptoms and taking appropriate precautions remain essential to reduce transmission and protect vulnerable populations. Ultimately, the emergence of Omicron demonstrated that COVID-19 continues to evolve, and its changing symptoms and rapid transmissibility mean that the pandemic should not be considered over.